Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Concateno joins on-the-spot testing market with £64m Cozart buy

This article was originally published in Clinica

Executive Summary

Drug and alcohol testing specialist Concateno is set to pay £64.4m ($129m) in cash for fellow UK company Cozart in a bid to gain on-the-spot testing capabilities. The deal will see Concateno pay 57.5p per Cozart share - a 41% premium over Cozart's closing share price on September 3.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts